Jobs / United States / Gilead Sciences INC
Director of US Pricing & Contracting Strategy, Virology
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles1 certified filing for “Sr Director, Commercial Product Strategy” (Marketing Managers) in CA: $272k–$272k, median $272k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description As Director of US Pricing & Contracting Strategy, Virology , you will: • Partner collaboratively with MMSO, GVA, Finance, legal, brand, and Public Affairs to develop short-term and longer-term USWAC pricing strategy; • deliver WAC-pricing recommendations to Senior Leadership for assigned in-line and pipeline products in the Virology portfolio, including for HIV Prevention. • Ensure Gilead leverages' best practices' in executing strategic pricing analysis, including managing vendor projects, assessing/acquiring data sources, analytic techniques and frameworks, etc. • Shape all aspects of their assigned products’ price concessions, including payer rebates, provider concessions, and pricing decisions. These gross-to-net levers impact millions of dollars in sales annually for a given brand and are critical to our overall success in the US market. • This strategic work includes the development, ongoing assessment, and execution of innovative and analytics-based contracting strategies in all provider (e.g. B&B clinic, HOPD, 340B) and payer (e.g. Commercial, Medicaid, Medicare, IDN, DOC) segments to meet competition and respond to changing marketplace dynamics. • Lead the contract strategy development and planning for assigned products over the different stages of the product life cycle (e.g., launch, post-launch, LOE). • Actively engage in Pricing and Contracting Governance Committee process. • Provide negotiation support to account teams, including those responsible for engaging with providers and regional payers, by clarifying the rationale behind contracting strategies, anticipating customer reactions and needs, and providing relevant negotiation talking points as appropriate. • Explore, develop, and maintain access and contracting strategies for clinic and hospital providers across the 340B segment. • Assess and develop value-based contractual agreements (i.e., VBAs) with payers, providers, and other stakeholders in the US healthcare ecosystem. • Evaluate provider discounting strategies aligning with interdependencies of payer rebate contracts. • Monitor contract/channel/product trends and identify issues and recommend solutions to leadership. • Maintain knowledge of product portfolio contracting strategy and all segments of the business, including the nuanced differences of different business • segments, e.g., Commercial, Medicare, Medicaid, and Federal. • Ensure brand access strategies are incorporated into pricing and contracting strategies, representing clinical value. • Lead insights generation and analysis to support the development and execution of access-related st